Pre-existing Toxoplasma gondii infection increases susceptibility to pentylenetetrazol-induced seizures independent of traumatic brain injury in mice

• Published in: Frontiers in molecular neuroscience 2023-01, Vol.15, p.1079097-1079097
• Main Authors: Baker, Tamara L, Uboldi, Alessandro D, Tonkin, Christopher J, Wright, David K, Vo, Anh, Wilson, Trevor, Mychasiuk, Richelle, McDonald, Stuart J, Semple, Bridgette D, Sun, Mujun, Shultz, Sandy R
• Format: Article
• Language: English
• Subjects: Animals; Brain research; Chronic infection; Convulsions & seizures; Custom design; Epilepsy; epileptogenesis; Females; Gene expression; Glutamatergic transmission; immune response; Infections; Inflammation; Males; Medical research; Mortality; neuroinflammation; Neuroscience; Oxidative stress; post-traumatic epilepsy (PTE); Protozoa; Risk factors; Seizures; Susceptibility; Tachyzoites; Toxoplasma gondii; Traumatic brain injury
• ISSN: 1662-5099; 1662-5099
• DOI: 10.3389/fnmol.2022.1079097

Post-traumatic epilepsy (PTE) is a debilitating chronic outcome of traumatic brain injury (TBI), and neuroinflammation is implicated in increased seizure susceptibility and epileptogenesis. However, how common clinical factors, such as infection, may modify neuroinflammation and PTE development has been understudied. The neurotropic parasite, incurably infects one-third of the world's population. Thus, many TBI patients have a pre-existing infection at the time of injury. infection results in chronic low-grade inflammation and altered signaling pathways within the brain, and preliminary clinical evidence suggest that it may be a risk factor for epilepsy. Despite this, no studies have considered how a pre-existing infection may alter the development of PTE. This study aimed to provide insight into this knowledge gap by assessing how a pre-existing infection alters susceptibility to, and severity of, pentylenetetrazol (PTZ)-induced seizures (i.e., a surrogate marker of epileptogenesis/PTE) at a chronic stage of TBI recovery. We hypothesized that will increase the likelihood and severity of seizures following PTZ administration, and that this would occur in the presence of intensified neuroinflammation. To test this, 6-week old male and female C57BL/6 Jax mice were intraperitoneally injected with 50,000 tachyzoites or with the PBS vehicle only. At 12-weeks old, mice either received a severe TBI controlled cortical impact or sham injury. At 18-weeks post-injury, mice were administered 40 mg/kg PTZ and video-recorded for evaluation of seizure susceptibility. Fresh cortical tissue was then collected for gene expression analyses. Although no synergistic effects were evident between infection and TBI, chronic infection alone had robust effects on the PTZ-seizure response and gene expression of markers related to inflammatory, oxidative stress, and glutamatergic pathways. In addition to this, females were more susceptible to PTZ-induced seizures than males. While TBI did not impact PTZ responses, injury effects were evident at the molecular level. Our data suggests that a pre-existing infection is an important modifier of seizure susceptibility independent of brain injury, and considerable attention should be directed toward delineating the mechanisms underlying this pro-epileptogenic factor.